Inventor · disambiguated record
Jamison Bryce Tuttle
Also filed as: TUTTLE JAMISON · TUTTLE JAMISON B · TUTTLE JAMISON BRYCE
15 granted patents·9 pending applications·24 citations·filing 2005–2025
88Inventor score
Files withPFIZER19CALIFORNIA INST OF TECHN2CLAFFEY MICHELLE M1DOUNAY AMY B1RIPARIAN PHARMACEUTICALS INC1
Top patents by PatentIndex Score
24 records- 0193US11452711B2Nitrile-containing antiviral compoundsPFIZER·Filed 2022·Granted Sep 27, 2022·3 cites·8 claims
- 0293US11351149B2Nitrile-containing antiviral compoundsPFIZER·Filed 2021·Granted Jun 7, 2022·6 cites·26 claims
- 0391US11541034B2Nitrile-containing antiviral compoundsPFIZER·Filed 2021·Granted Jan 3, 2023·2 cites·30 claims
- 0484US2025099424A1Nitrile-Containing Antiviral CompoundsPFIZER·Filed 2024·Application pending·0 cites
- 0583US8933224B2Triazine derivativesPFIZER·Filed 2014·Granted Jan 13, 2015·5 cites·24 claims
- 0681US11684616B2Azalactam compounds as HPK1 inhibitorsPFIZER·Filed 2021·Granted Jun 27, 2023·1 cites·33 claims
- 0778US9296761B2Triazine derivativesPFIZER·Filed 2015·Granted Mar 29, 2016·2 cites·23 claims
- 0876US2023120254A1Nitrile-Containing Antiviral CompoundsPFIZER·Filed 2022·Application pending·0 cites
- 0974US8183238B2Bicyclic and tricyclic compounds as KAT II inhibitorsCLAFFEY MICHELLE M·Filed 2010·Granted May 22, 2012·5 cites·13 claims
- 1067US2024197703A1Azalactam Compounds as HPK1 InhibitorsPFIZER·Filed 2023·Application pending·0 cites
- 1163US2025051246A1Deuterated Antiviral CompoundsPFIZER·Filed 2024·Application pending·0 cites
- 1259US2025109143A1Klf2 inducing deuterated compounds and uses thereofRIPARIAN PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1356US11390623B26,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligandsPFIZER·Filed 2020·Granted Jul 19, 2022·0 cites·40 claims
- 1455US2025304559A1Ether-Linked Antiviral CompoundsPFIZER·Filed 2022·Application pending·0 cites
- 1554US12485157B2Method of treating COVID-19PFIZER·Filed 2021·Granted Dec 2, 2025·0 cites·21 claims
- 1654US12358897B2Compounds and method of treating COVID-19PFIZER·Filed 2021·Granted Jul 15, 2025·0 cites·23 claims
- 1752US2025346567A1Substituted pyridine and phenyl compoundsPFIZER·Filed 2025·Application pending·0 cites
- 1852US2008125310A1Hydride reduction of alpha, beta-unsaturated carbonyl compounds using chiral organic catalystsCALIFORNIA INST OF TECHN·Filed 2007·Application pending·0 cites
- 1950US11926642B2Compounds and methods for the treatment of COVID-19PFIZER·Filed 2021·Granted Mar 12, 2024·0 cites·19 claims
- 2049US7323604B2Hydride reduction of α,β-unsaturated carbonyl compounds using chiral organic catalystsCALIFORNIA INST OF TECHN·Filed 2005·Granted Jan 29, 2008·0 cites·13 claims
- 2146US10590128B26,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligandsPFIZER·Filed 2017·Granted Mar 17, 2020·0 cites·29 claims
- 2244US11142525B2Azalactam compounds as HPK1 inhibitorsPFIZER·Filed 2019·Granted Oct 12, 2021·0 cites·40 claims
- 2343US2015175603A1Tricyclic compounds as kat ii inhibitorsPFIZER·Filed 2013·Application pending·0 cites
- 2442US8487104B2KAT II inhibitorsDOUNAY AMY B·Filed 2011·Granted Jul 16, 2013·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Jamison Bryce Tuttle files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →